[
  {
    "ts": null,
    "headline": "Zoetis Inc. (ZTS): A Bull Case Theory",
    "summary": "We came across a bullish thesis on Zoetis Inc. (NYSE:ZTS) on Substack by Best Anchor Stocks. In this article, we will summarize the bulls’ thesis on ZTS. Zoetis Inc. (NYSE:ZTS)’s share was trading at $164.70 as of Dec 24th. ZTS’s trailing and forward P/E were 30.96 and 28.41 respectively according to Yahoo Finance. Zoetis delivered an impressive […]",
    "url": "https://finnhub.io/api/news?id=87a7aa4a22e08ae7098a0885577568ed64206eb7d13db74dbd9f6d8b2bc82317",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1735230921,
      "headline": "Zoetis Inc. (ZTS): A Bull Case Theory",
      "id": 132166530,
      "image": "https://media.zenfs.com/en/insidermonkey.com/378849badf14a3300590373b11507139",
      "related": "ZTS",
      "source": "Yahoo",
      "summary": "We came across a bullish thesis on Zoetis Inc. (NYSE:ZTS) on Substack by Best Anchor Stocks. In this article, we will summarize the bulls’ thesis on ZTS. Zoetis Inc. (NYSE:ZTS)’s share was trading at $164.70 as of Dec 24th. ZTS’s trailing and forward P/E were 30.96 and 28.41 respectively according to Yahoo Finance. Zoetis delivered an impressive […]",
      "url": "https://finnhub.io/api/news?id=87a7aa4a22e08ae7098a0885577568ed64206eb7d13db74dbd9f6d8b2bc82317"
    }
  },
  {
    "ts": null,
    "headline": "The Wall Street Journal Vs. Zoetis",
    "summary": "Debunking claims of safety concerns around Zoetis Inc.'s OA pain drug, Librela. Click here for our updated look at ZTS stock and a look ahead.",
    "url": "https://finnhub.io/api/news?id=461aae0970636b3764c44f0dc91a0711dcf8449357c383ac285e9774bb574701",
    "source": "SeekingAlpha",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1735209149,
      "headline": "The Wall Street Journal Vs. Zoetis",
      "id": 132164665,
      "image": "https://static.seekingalpha.com/cdn/s3/uploads/getty_images/1885088156/image_1885088156.jpg?io=getty-c-w1536",
      "related": "ZTS",
      "source": "SeekingAlpha",
      "summary": "Debunking claims of safety concerns around Zoetis Inc.'s OA pain drug, Librela. Click here for our updated look at ZTS stock and a look ahead.",
      "url": "https://finnhub.io/api/news?id=461aae0970636b3764c44f0dc91a0711dcf8449357c383ac285e9774bb574701"
    }
  }
]